$TRUP

GALLAGHER JOHN R sold $78K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 3,603 shares of TRUPANION, INC. (TRUP) at $21.69 on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Jun 2, 2026, 12:34 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 1:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
medium confidence
Mentioned
$TRUP
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The disclosure provides transparency on insider activity but does not, by itself, indicate a new operational or financial development.

02

Market read

A disclosed 10b5-1 insider sale in TRUP; expected to be low-signal for fundamentals.

03

What to watch

The filing date may lag the sale date; the market reaction (if any) would depend on whether the sale was already anticipated or coincided with other news.

Relevance 6/10Novelty 3/10Timing: Filed June 1; sale executed May 28 under a 10b5-1 plan.

Background

This is an SEC Form 4 insider transaction for TRUPANION, Inc. (TRUP) by its COO, disclosed as an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$TRUPNeutralMedium confidence
Context

TRUPANION COO John R Gallagher sold 3,603 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited near-term impact; any move would be more sentiment/flow-driven than fundamental.

Evidence & confidence

Form 4 shows a scheduled 10b5-1 sale rather than an unscheduled discretionary trade, so informational content is typically lower.

Market effects

Minimal—single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with internal caution; traders may still watch for follow-on selling or other insider actions.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction was reported; COO John R Gallagher sold shares under a 10b5-1 plan.

  • GALLAGHER JOHN R

    Chief Operating Officer who executed the reported open-market sale.

  • Rule 10b5-1 plan

    Pre-arranged trading plan that typically lowers the informational value of the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended